Companies: 10,795·Total market cap: $144.5T

Genetic Technologies Limited

Genetic Technologies Limited

GNTLFOTCHealthcare● Active

$1.00

+$0.00(+0.00%)

Market Cap$1.3B

P/E Ratio—

52W High$1

52W Low$1

Avg Volume65.2

Open$1.00

Beta0.17

股票排行：Medical - Diagnostics & Research·Healthcare·查看全部市值排行 →

Genetic Technologies Limited（GNTLF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GNTLF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.18Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$13.7MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding138.4MShares outstanding history

Next EarningsAug 27, 2026Est.Earnings history

探索 Genetic Technologies Limited 数据

分析师预测$— · Sell

股息不分红

营收$9.7M-6.52%

盈利EPS $-0.09+24.25%

财务快照

FY 2024Revenue$9.7M▼ 6.52% YoY

202220232024

FY 2024Net Income-$12.0M▼ 2.27% YoY

202220232024

FY 2024EPS$-0.09▲ +24.25% YoY

202220232024

TTM:Revenue: $13.7MNet Income: -$22.4MEPS: $-0.18View income statement →

分析师评级与目标价

Sell1 位分析师

Strong Buy

0

Buy

0

Hold

0

Sell

1

Strong Sell

0

12-Month Price Target

$—Low

$1.00Current

$—Avg Target

$—High

合计: 1 · 买入占比: 0.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Genetic Technologies Limited

$1.00+0.00%$1.3B #2

China Traditional Chinese Medicine Holdings Co. Limited

$0.27+24.87%$1.4B #3

Cosmo Pharmaceuticals N.V.

$90.00-1.25%$1.5B #4

CStone Pharmaceuticals

$0.70+0.00%$1.1B #5

$6.69+0.00%$1.2B #6

H.U. Group Holdings, Inc.

$20.26-4.73%$1.1B

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y+233.33%

关于 Genetic Technologies Limited

CEOKevin Camilleri

IPO DateOct 19, 2000

Employees55

CountryAU

Websitegtglabs.com

Genetic Technologies Limited trading as GNTLF, is an Australian molecular diagnostics enterprise dedicated to creating and delivering advanced predictive assessment instruments. These tools are desig…

Medical - Diagnostics & Research HealthcareOTCAU

关于股票概览与关键数据

Genetic Technologies Limited（GNTLF）是 Medical - Diagnostics & Research 行业的 Healthcare 类公司，于 Oct 19, 2000 在 OTC 上市。截至最近交易日，GNTLF 股价为 $1.00，市值约为 $1.3B。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

根据 1 位华尔街分析师，Genetic Technologies Limited 股票共识评级为Sell，12个月平均目标价为 $—。2024 财年 Genetic Technologies Limited 营收 $9.7M，净利润 -$12.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Genetic Technologies Limited（GNTLF）股价为 $1.00，在 OTC 上市，52周区间为 $1.00 – $1.00。

GNTLF 最新股价GNTLF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议